Quadratus Lumborum Block Versus Epidural for Laparoscopic Nephrectomy Kidney Donor

October 21, 2019 updated by: Aida Rosita Tantri, Indonesia University

Comparison Between Quadratus Lumborum Block and Epidural on Stress Response and Perioperative Cellular Immunological Function of Laparoscopic Nephrectomy Kidney Donor

This study aimed to compare Quadratus Lumborum Block to Epidural on Stress Response and Perioperative Cellular Immunological Function of Laparoscopic Nephrectomy Kidney Donor

Study Overview

Detailed Description

Sixty-two subjects were given informed consent before enrolling the study and randomized into two groups; quadratus lumborum block and epidural. Non-invasive blood pressure monitor, electrocardiogram (ECG), and pulse-oxymetry were set on the subjects in the operation room. General anesthesia induction was done by fentanyl 2 mcg/kg and propofol 1-2 mg/kg. Endotracheal tube (ETT) intubation was facilitated with Atracurium 0.5mg/kg as muscle relaxant. Maintenance was done by sevoflurane, oxygen, and compressed air. On quadratus lumborum block group, bilateral block using ultrasound will be performed with stimuplex 100mm needle with 20 cc of bupivacaine 0.25% as regimen. On epidural group, epidural catheter was inserted under general anaesthesia on left lateral decubitus position (5 cm depth inside the epidural space) at level Th10-Th11. The catheter insertion was confirmed with vacuum aspiration and negative test-dose. Before first incision, patient will be given continuous epidural Bupivacaine 0.25% 6 mL/hour. Blood sample was drawn for interleukin-6, blood glucose, and c-reactive protein as baseline data. After surgery, patient were extubated until fully conscious and can follow command verbally. Patient will be transported in recovery room post operation.

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • DKI Jakarta
      • Jakarta Pusat, DKI Jakarta, Indonesia, 10430
        • Cipto Mangunkusumo Central National Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Kidney donor patients undergoing laparoscopic nephrectomy
  • Body mass index below 30
  • Duration of surgery 4 to 6 hours
  • Patients who agreed to participate in this study and sign informed consent.

Exclusion Criteria:

Have contraindication for quadratus lumborum block

  • Have contraindication for epidural
  • Previous history of local anesthetic drug allergy
  • inability to communicate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Quadratus Lumborum Block
Patient will receive quadratus lumborum block
Bilateral block using ultrasound will be performed before surgery and after surgery on patient using Stimuplex 100mm needle with Bupivacaine 0.25% 0.4 mL/kg, maximum dose 25 mL each side under general anaesthesia
Active Comparator: Continuous Epidural
Patient will receive epidural anesthesia
Patient will be given 6 mL/hour of Bupivacaine 0.25% for intraoperative analgesia and continued epidural 6 mL/hour Bupivacaine 0,125% as postoperative analgesia in 24 hours.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline Interleukin-6 at 24 hours after abdominal insufflation
Time Frame: Before procedure, at the end of surgery, and 24 hours after abdominal insufflation
Measure by ELISA
Before procedure, at the end of surgery, and 24 hours after abdominal insufflation
Cumulative morphine requirement at 2 hours, 6 hours, 12 hours, 24 hours postoperative
Time Frame: 2 hours, 6 hours, 12 hours, 24 hours.
Cumulative morphine consumption at each time point in 24 hours after surgery
2 hours, 6 hours, 12 hours, 24 hours.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline Patient Controlled Analgesia at 2, 6, 12 and 24 hours after procedure
Time Frame: 2, 6, 12, and 24 hours after procedure
Measure by how many times patient use morphine PCA analgesia
2, 6, 12, and 24 hours after procedure
Change from Baseline Pain Intensity at 2, 6, 12, and 24 hours after procedure
Time Frame: 2, 6, 12, and 24 hours after procedure
Measured by Numerical Rating Scale
2, 6, 12, and 24 hours after procedure
Change from Baseline Blood Glucose at 2 hours after abdominal insufflation
Time Frame: Before procedure and 2 hours after abdominal insufflation
Measured by finger-stick blood sample
Before procedure and 2 hours after abdominal insufflation
Change from Baseline Blood pressure
Time Frame: Intraoperative and 24 hours
Measured by non-invasive blood pressure monitoring at before anaesthesia induction (baseline), post-induction, gas-insufflation, Pfannenstiel incision, end of surgery, and 24 hours surgery
Intraoperative and 24 hours
Change from Baseline Mean Arterial Pressure
Time Frame: Intraoperative and 24 hours
Measured by non-invasive blood pressure monitoring at before anaesthesia induction (baseline), post-induction, gas-insufflation, Pfannenstiel incision, end of surgery, and 24 hours surgery
Intraoperative and 24 hours
Change from Baseline Cardiac Index
Time Frame: Intraoperative and 24 hours
Measured by cardiometry ICON® at before anaesthesia induction (baseline), post-induction, gas-insufflation, Pfannenstiel incision, end of surgery, and 24 hours surgery
Intraoperative and 24 hours
Change from Baseline Heart Rate
Time Frame: Intraoperative and 24 hours
Measured by pulse oximetry at before anaesthesia induction (baseline), post-induction, gas-insufflation, Pfannenstiel incision, end of surgery, and 24 hours surgery
Intraoperative and 24 hours
Change from Baseline hs-CRP at 48 hours after abdominal insufflation
Time Frame: Before procedure, at the end of surgery, and 48 hours after abdominal insufflation
Measured with ELISA
Before procedure, at the end of surgery, and 48 hours after abdominal insufflation
Time to first morphine requirement
Time Frame: 24 hours
Duration from end of anesthesia until first attempt of morphine requirement in minutes
24 hours
Total bupivacaine used in 24 hours
Time Frame: 24 hours
Total bupivacaine used until 24 hours postoperatively
24 hours
Change from baseline motor block at 2, 6, 12, and 24 hours after anesthesia recovery
Time Frame: 2, 6, 12, and 24 hours after procedure
Measured by Bromage score
2, 6, 12, and 24 hours after procedure
Number of participants with paresthesia after procedure
Time Frame: 24 hours
in percentage
24 hours
Duration of urinary catheter
Time Frame: 24 hours
in hours
24 hours
Level of sensory block after procedure
Time Frame: 24 hours
Measured by cold and pin prick sensation
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Actual)

October 30, 2018

Study Completion (Actual)

December 31, 2018

Study Registration Dates

First Submitted

April 15, 2018

First Submitted That Met QC Criteria

April 26, 2018

First Posted (Actual)

May 9, 2018

Study Record Updates

Last Update Posted (Actual)

October 22, 2019

Last Update Submitted That Met QC Criteria

October 21, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Transplant Donor of Left Kidney

Clinical Trials on Quadratus Lumborum Block

Subscribe